Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination comprising anti-fibroblast growth factor receptor 2 (FGFR2) antibody and a tyrosine kinase inhibitor

Combination comprising anti-fibroblast growth factor receptor 2 (FGFR2) antibody and a tyrosine kinase inhibitor

US Patent 9931401 · Granted Apr 3, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination of antibody-drug conjugate and tubulin inhibitor2025
Combination of antibody-drug conjugate and immune checkpoint inhibitor2025
Combination of antibody-drug conjugate and immune checkpoint inhibitor2022
Anti-FGFR2 antibodies and methods of use thereof for treating cancer2017
Anti-FGFR2 antibodies and methods of use thereof for treating cancer2017
Anti-FGFR2 antibodies and pharmaceutical compositions thereof2016
Anti-FGFR2 antibodies and pharmaceutical compositions thereof2016
Anti B7-H3 antibody2016
Anti-EPHA2 antibody2015
Anti-EPHA2 antibody2013